Status: Recruiting
Reducing Mortality in Adults With Advanced HIV Disease (REVIVE)
A double blinded, placebo-controlled, multicenter trial to evaluate effectiveness of azithromycin prophylaxis on mortality in advanced HIV.
Participants needed: 8,000
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Population Health Research InstituteUpdated: Sep 3, 2025Locations: 52
Eligibility criteria
Age ≥ 18 years [+2]
Severe illness requiring immediate or continued hospitalization (this will be in... [+1]